Medtronic plc. (MDT) Shares Sold by Rothschild Asset Management Inc.

Rothschild Asset Management Inc. lowered its position in Medtronic plc. (NYSE:MDT) by 3.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 732,425 shares of the medical technology company’s stock after selling 23,708 shares during the quarter. Rothschild Asset Management Inc. owned about 0.05% of Medtronic worth $56,961,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust increased its holdings in shares of Medtronic by 22.4% in the second quarter. Parkside Financial Bank & Trust now owns 1,146 shares of the medical technology company’s stock worth $102,000 after purchasing an additional 210 shares during the period. BDO Wealth Advisors LLC bought a new position in shares of Medtronic in the second quarter worth $103,000. Motco increased its holdings in shares of Medtronic by 8.7% in the second quarter. Motco now owns 1,239 shares of the medical technology company’s stock worth $110,000 after purchasing an additional 99 shares during the period. Farmers National Bank bought a new position in shares of Medtronic in the first quarter worth $121,000. Finally, Blue Chip Partners Inc. bought a new position in shares of Medtronic in the third quarter worth $118,000. 81.72% of the stock is currently owned by hedge funds and other institutional investors.

In other news, EVP Bryan C. Hanson sold 16,000 shares of the firm’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $79.02, for a total transaction of $1,264,320.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have sold 48,000 shares of company stock worth $3,837,920 over the last ninety days. Insiders own 0.31% of the company’s stock.

MDT has been the topic of several research analyst reports. Royal Bank of Canada decreased their price target on shares of Medtronic from $90.00 to $85.00 and set an “outperform” rating on the stock in a report on Monday, October 9th. Zacks Investment Research raised Medtronic from a “sell” rating to a “hold” rating in a research note on Wednesday, September 6th. SunTrust Banks set a $92.00 target price on Medtronic and gave the company a “buy” rating in a research note on Sunday, November 19th. Jefferies Group reissued a “buy” rating and issued a $99.00 target price on shares of Medtronic in a research note on Thursday, November 23rd. Finally, Northland Securities reissued a “hold” rating and issued a $80.00 target price on shares of Medtronic in a research note on Wednesday, November 22nd. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Medtronic presently has a consensus rating of “Hold” and a consensus target price of $88.57.

Medtronic plc. (NYSE MDT) opened at $81.54 on Tuesday. Medtronic plc. has a 12 month low of $69.35 and a 12 month high of $89.72. The stock has a market capitalization of $110,364.22, a PE ratio of 22.34, a PEG ratio of 2.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.05 and a current ratio of 2.40.

Medtronic (NYSE:MDT) last announced its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.99 by $0.08. Medtronic had a return on equity of 12.63% and a net margin of 16.93%. The firm had revenue of $7.05 billion for the quarter, compared to analysts’ expectations of $7.05 billion. During the same period last year, the firm earned $1.12 earnings per share. The company’s revenue for the quarter was down 4.0% compared to the same quarter last year. sell-side analysts anticipate that Medtronic plc. will post 4.77 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 19th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.46 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.26%. Medtronic’s dividend payout ratio (DPR) is currently 50.41%.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.com-unik.info/2017/12/26/medtronic-plc-mdt-shares-sold-by-rothschild-asset-management-inc.html.

Medtronic Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit